138 related articles for article (PubMed ID: 32278495)
1. Consequences of hyperphosphorylated tau on the morphology and excitability of hippocampal neurons in aged tau transgenic mice.
Müller-Thomsen L; Borgmann D; Morcinek K; Schröder S; Dengler B; Moser N; Neumaier F; Schneider T; Schröder H; Huggenberger S
Neurobiol Aging; 2020 Sep; 93():109-123. PubMed ID: 32278495
[TBL] [Abstract][Full Text] [Related]
2. Hyperphosphorylated tau causes reduced hippocampal CA1 excitability by relocating the axon initial segment.
Hatch RJ; Wei Y; Xia D; Götz J
Acta Neuropathol; 2017 May; 133(5):717-730. PubMed ID: 28091722
[TBL] [Abstract][Full Text] [Related]
3. Altered function of hippocampal CA1 pyramidal neurons in the rTg4510 mouse model of tauopathy.
Dalby NO; Volbracht C; Helboe L; Larsen PH; Jensen HS; Egebjerg J; Elvang AB
J Alzheimers Dis; 2014; 40(2):429-42. PubMed ID: 24448785
[TBL] [Abstract][Full Text] [Related]
4. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
Helboe L; Egebjerg J; Barkholt P; Volbracht C
Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
[TBL] [Abstract][Full Text] [Related]
5. Changes in dendritic complexity and spine morphology in transgenic mice expressing human wild-type tau.
Dickstein DL; Brautigam H; Stockton SD; Schmeidler J; Hof PR
Brain Struct Funct; 2010 Mar; 214(2-3):161-79. PubMed ID: 20213269
[TBL] [Abstract][Full Text] [Related]
6. Improved long-term potentiation and memory in young tau-P301L transgenic mice before onset of hyperphosphorylation and tauopathy.
Boekhoorn K; Terwel D; Biemans B; Borghgraef P; Wiegert O; Ramakers GJ; de Vos K; Krugers H; Tomiyama T; Mori H; Joels M; van Leuven F; Lucassen PJ
J Neurosci; 2006 Mar; 26(13):3514-23. PubMed ID: 16571759
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of Tau protein correlates with changes in hippocampal theta oscillations and reduces hippocampal excitability in Alzheimer's model.
Mondragón-Rodríguez S; Salas-Gallardo A; González-Pereyra P; Macías M; Ordaz B; Peña-Ortega F; Aguilar-Vázquez A; Orta-Salazar E; Díaz-Cintra S; Perry G; Williams S
J Biol Chem; 2018 Jun; 293(22):8462-8472. PubMed ID: 29632073
[TBL] [Abstract][Full Text] [Related]
8. The GABAergic septohippocampal connection is impaired in a mouse model of tauopathy.
Soler H; Dorca-Arévalo J; González M; Rubio SE; Ávila J; Soriano E; Pascual M
Neurobiol Aging; 2017 Jan; 49():40-51. PubMed ID: 27743524
[TBL] [Abstract][Full Text] [Related]
9. Frontotemporal Dementia P301L Mutation Potentiates but Is Not Sufficient to Cause the Formation of Cytotoxic Fibrils of Tau.
Wang KW; Zhang G; Kuo MH
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834443
[TBL] [Abstract][Full Text] [Related]
10. Impaired plasticity of cortical dendritic spines in P301S tau transgenic mice.
Hoffmann NA; Dorostkar MM; Blumenstock S; Goedert M; Herms J
Acta Neuropathol Commun; 2013 Dec; 1():82. PubMed ID: 24344647
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of p25/Cdk5 Attenuates Tauopathy in Mouse and iPSC Models of Frontotemporal Dementia.
Seo J; Kritskiy O; Watson LA; Barker SJ; Dey D; Raja WK; Lin YT; Ko T; Cho S; Penney J; Silva MC; Sheridan SD; Lucente D; Gusella JF; Dickerson BC; Haggarty SJ; Tsai LH
J Neurosci; 2017 Oct; 37(41):9917-9924. PubMed ID: 28912154
[TBL] [Abstract][Full Text] [Related]
12. Early improved and late defective cognition is reflected by dendritic spines in Tau.P301L mice.
Kremer A; Maurin H; Demedts D; Devijver H; Borghgraef P; Van Leuven F
J Neurosci; 2011 Dec; 31(49):18036-47. PubMed ID: 22159117
[TBL] [Abstract][Full Text] [Related]
13. Sex Impact on Tau-Aggregation and Postsynaptic Protein Levels in the P301L Mouse Model of Tauopathy.
Buccarello L; Grignaschi G; Castaldo AM; Di Giancamillo A; Domeneghini C; Melcangi RC; Borsello T
J Alzheimers Dis; 2017; 56(4):1279-1292. PubMed ID: 28157099
[TBL] [Abstract][Full Text] [Related]
14. Accelerated aging exacerbates a pre-existing pathology in a tau transgenic mouse model.
Bodea LG; Evans HT; Van der Jeugd A; Ittner LM; Delerue F; Kril J; Halliday G; Hodges J; Kiernan MC; Götz J
Aging Cell; 2017 Apr; 16(2):377-386. PubMed ID: 28160413
[TBL] [Abstract][Full Text] [Related]
15. Tau-dependent Kv4.2 depletion and dendritic hyperexcitability in a mouse model of Alzheimer's disease.
Hall AM; Throesch BT; Buckingham SC; Markwardt SJ; Peng Y; Wang Q; Hoffman DA; Roberson ED
J Neurosci; 2015 Apr; 35(15):6221-30. PubMed ID: 25878292
[TBL] [Abstract][Full Text] [Related]
16. Hippocampal neuronal subpopulations are differentially affected in double transgenic mice overexpressing frontotemporal dementia and parkinsonism linked to chromosome 17 tau and glycogen synthase kinase-3beta.
Engel T; Goñi-Oliver P; Gomez-Ramos P; Morán MA; Lucas JJ; Avila J; Hernández F
Neuroscience; 2008 Dec; 157(4):772-80. PubMed ID: 18951953
[TBL] [Abstract][Full Text] [Related]
17. Intravenous immunoglobulin reduces tau pathology and preserves neuroplastic gene expression in the 3xTg mouse model of Alzheimer's disease.
Counts SE; Perez SE; He B; Mufson EJ
Curr Alzheimer Res; 2014; 11(7):655-63. PubMed ID: 25156574
[TBL] [Abstract][Full Text] [Related]
18. Increased O-GlcNAcylation reduces pathological tau without affecting its normal phosphorylation in a mouse model of tauopathy.
Graham DL; Gray AJ; Joyce JA; Yu D; O'Moore J; Carlson GA; Shearman MS; Dellovade TL; Hering H
Neuropharmacology; 2014 Apr; 79():307-13. PubMed ID: 24326295
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the cholinergic pathology in the P301L tau transgenic pR5 model of tauopathy.
Köhler C; Bista P; Götz J; Schröder H
Brain Res; 2010 Aug; 1347():111-24. PubMed ID: 20513372
[TBL] [Abstract][Full Text] [Related]
20. Divergent phosphorylation pattern of tau in P301L tau transgenic mice.
Deters N; Ittner LM; Götz J
Eur J Neurosci; 2008 Jul; 28(1):137-47. PubMed ID: 18662339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
